Streetbeat News

Stock Prices

GAU

Galiano Gold (AMEX:GAU) reported Q1 2024 adjusted EPS of $0.03, beating estimates by 50% but showing a 25% decrease from the previous year. Sales of $65.602M missed estimates by 0.60%, yet marked a 0.63% increase year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:12 pm

MX

MagnaChip Semiconductor's shares surged following the announcement of their Q1 2024 earnings, which exceeded analysts' expectations for both adjusted EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:11 pm

SM

SM Energy (NYSE:SM) reported Q1 2024 earnings of $1.41 per share, surpassing the consensus estimate of $1.28, and sales of $559.870M, slightly above the estimate of $558.312M. This represents a 6.02% increase in earnings per share and a 2.38% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:10 pm

IBRX

ImmunityBio's stock is trading higher following the announcement of an exclusive global arrangement with the Serum Institute of India for the supply of Bacillus Calmette-Guerin.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:10 pm

FIVN

Five9 shares surged following the announcement of its Q1 financial results, which exceeded expectations. Additionally, the company increased its forecast for FY24 adjusted EPS, signaling stronger future performance.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:07 pm

PBYI

Puma Biotechnology (NASDAQ:PBYI) reported Q1 2024 adjusted EPS of $(0.05), surpassing the $(0.22) estimate, with sales of $43.800M exceeding the $41.050M forecast. This represents a significant decrease in earnings and a slight decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:06 pm

LMAT

LeMaitre Vascular (NASDAQ:LMAT) reported Q1 2024 earnings of $0.44 per share, surpassing the $0.38 estimate, a 62.96% increase from last year. Sales reached $53.478M, beating the $51.506M estimate, marking a 13.60% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:06 pm

PCTY

Paylocity Holding's shares surged following the announcement of Q3 financial results that exceeded expectations. The company also provided optimistic Q4 and FY24 revenue guidance, alongside a $500 million share repurchase program approved by the Board of Directors.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:06 pm

HSY

Hershey Co (HSY) is set to report Q1 earnings with expectations of $2.76 EPS and $3.112 billion in revenues. Despite a 30% decline over the past year, the stock is up 4.44% YTD. Hershey's ability to manage cocoa price inflation positions it well against competitors, potentially benefiting from expanded margins if cocoa prices revert. Technical analysis shows a bullish trend for HSY stock, despite some indicators suggesting potential overbought conditions. Analyst consensus rates HSY as Neutral with a price target suggesting a slight downside.

Portfolio Pulse from Surbhi Jain

May 02, 2024 | 9:05 pm

ENGN

enGene Holdings Inc. (NASDAQ:ENGN) announced its participation in the American Urology Association 2024 Annual Meeting to present details of its Phase 1/2 LEGEND study of EG-70, a non-viral gene therapy for BCG-unresponsive non-muscle invasive bladder cancer. The presentation will highlight EG-70's design, addressing challenges of other treatments, and share promising initial efficacy and safety data. Complete response rates in the Phase 1 subgroup showed 70% and 60% at three and six months, respectively, indicating potential for durable remissions without significant quality of life impairment.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 9:05 pm